Short answer
Benitec Biopharma Inc. (BNTC) filed an 8-K current report with the SEC on September 24, 2026 reporting Item 4.01 (Changes in Registrant's Certifying Accountant). Audit Committee appointed EY as independent auditor for fiscal year ending June 30, 2027.
- This filing includes Item 4.01, an item that often signal trouble.
Benitec Biopharma Inc. 8-K event analysis
AI summary of each reported item and its exhibits
Item 4.01 · Changes in Registrant's Certifying Accountant
- Audit Committee appointed EY as independent auditor for fiscal year ending June 30, 2027
- EY engagement remains subject to completion of its client acceptance process
- No consultations with EY involving accounting treatments, audit opinions, disagreements, or reportable events
- Auditor transition disclosed without identified accounting disputes or reportable issues
Generated from the filing text and exhibits; verify against the original. What 8-K item codes mean
Other Benitec Biopharma Inc. 8-K filings
Get the next BNTC 8-K as it lands
Follow BNTC for push alerts, or ask the research agent what this filing means.